The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis.

Abstract

BACKGROUND Tumor programmed death ligand one (PD-L1) expression has been studied in several trials in non-small-cell lung cancer. METHODS We assessed the potential role of PD-L1 expression according to Cochrane Collaboration's Guidelines. RESULTS 13 studies with 1979 patients were included. Among 915 PD-L1 negative patients this rate was 13% (RR 2.08… (More)
DOI: 10.2217/imt-2015-0002

Topics

Statistics

05010020172018
Citations per Year

64 Citations

Semantic Scholar estimates that this publication has 64 citations based on the available data.

See our FAQ for additional information.

  • Presentations referencing similar topics